1月6日 - ** 医疗设备制造商AngiodynamicsANGO.O的股价在盘前交易中上涨约8%，至14.28美元。
** 公司将2026财年净销售额预期从 之前的3.08亿至3.13亿美元上调至3.12亿至3.14亿美元。
** 还将年度调整后息税折旧摊销前利润（EBITDA）上调至800万美元至1000万美元之间，之前的 上调幅度为600万美元至1000万美元
** 公司报告第二季度净亏损 640 万美元，去年同期净亏损 1070 万美元
** 一旦公司任命继任者，Jim Clemmer 将于 2027 财年卸任总裁兼首席执行官一职。
** 2025 年 ANGO 股价上涨约 40
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.